Transcutaneous Auricular Vagus Nerve Stimulation to Enhance Motor Learning
NCT ID: NCT05316519
Last Updated: 2024-05-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
4 participants
INTERVENTIONAL
2022-06-01
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pupil-Indexed Noninvasive Neuromodulation
NCT06282406
Learning and Ear Stimulation
NCT04812015
Noninvasive Vagus Nerve Stimulation (VNS) for Neuromotor Adaptations
NCT03628976
Testing the Noradrenergic Hypothesis of Transcutaneous Vagus Nerve Stimulation
NCT04455295
Effect of Stimulation on the Vagus Nerve
NCT04206540
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Transcutaneous Vagus Nerve Stimulation
Transcutaneous vagus nerve stimulation paired with visuomotor task training
Transcutaneous Vagus Nerve Stimulation
Visuomotor task training with transcutaneous stimulation targeting landmark that activates biomarker
Transcutaneous Stimulation (Sham)
Transcutaneous stimulation paired with visuomotor task training
Transcutaneous Vagus Nerve Stimulation
Visuomotor task training with transcutaneous stimulation targeting landmark that activates biomarker
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Transcutaneous Vagus Nerve Stimulation
Visuomotor task training with transcutaneous stimulation targeting landmark that activates biomarker
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Confirmed diagnosis of a single stroke at least six months prior to participation
Exclusion Criteria
* Diagnosis of neurological disorders affecting movement
* Ocular disease and/or impairment in more than one eye
* Pregnant or expecting to become pregnant
* Difficulty maintaining alertness and/or remaining still
18 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
VA Pittsburgh Healthcare System
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Michael A. Urbin
Scientist
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Human Engineering Research Laboratories
Pittsburgh, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1619399
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.